New Anti-Cancer Agents Targeting VEGFR-2
Author Information
Author(s): Aboshouk Dalia R., Youssef M. Adel, Panda Siva S., Kariuki Benson M., Bekheit Mohamed S., Hamed Ahmed R., Fayad Walid, Soliman Ahmed A. F.
Primary Institution: National Research Centre, Egypt
Hypothesis
The study investigates the synthesis of novel antiproliferative 2-oxoindolin-3-ylidenes with potential VEGFR-2 inhibitory properties.
Conclusion
Some synthesized agents showed higher efficacy against cancer cell lines than the standard drug sunitinib.
Supporting Evidence
- Compound 12b showed 87.2% inhibition against VEGFR-2, comparable to sunitinib's 89.4%.
- Most synthesized agents exhibited better antiproliferation properties against HCT116, MCF7, and PaCa2 cancer cell lines than sunitinib.
- Molecular docking studies supported the observed antiproliferation effects.
Takeaway
Scientists created new drugs that might help fight cancer by blocking a specific protein that helps tumors grow.
Methodology
The agents were synthesized through a two-step reaction involving isatin and urea derivatives, followed by testing their antiproliferative properties against cancer cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website